Banks - Regional
Compare Stocks
5 / 10Stock Comparison
CHYM vs MQ vs SOFI vs DAVE vs UPST
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Financial - Credit Services
Software - Application
Financial - Credit Services
CHYM vs MQ vs SOFI vs DAVE vs UPST — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Software - Infrastructure | Financial - Credit Services | Software - Application | Financial - Credit Services |
| Market Cap | $7.61B | $1.78B | $20.40B | $3.35B | $2.78B |
| Revenue (TTM) | $2.19B | $652M | $4.77B | $552M | $1.08B |
| Net Income (TTM) | $-969M | $2M | $481M | $225M | $49M |
| Gross Margin | 85.9% | 70.0% | 75.1% | 81.5% | 95.2% |
| Operating Margin | -47.6% | -4.0% | 11.0% | 4.9% | 5.1% |
| Forward P/E | 112.9x | 250.9x | 26.5x | 19.1x | 14.7x |
| Total Debt | $135M | $22M | $1.82B | $75M | $1.85B |
| Cash & Equiv. | $466M | $982M | $4.93B | $81M | $657M |
CHYM vs MQ vs SOFI vs DAVE vs UPST — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Chime Financial, In… (CHYM) | 100 | 55.1 | -44.9% |
| Marqeta, Inc. (MQ) | 100 | 71.9 | -28.1% |
| SoFi Technologies, … (SOFI) | 100 | 87.9 | -12.1% |
| Dave Inc. (DAVE) | 100 | 92.9 | -7.1% |
| Upstart Holdings, I… (UPST) | 100 | 44.8 | -55.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHYM vs MQ vs SOFI vs DAVE vs UPST
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHYM is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 2.50, Low D/E 9.6%, current ratio 4.53x
- Beta 2.50, current ratio 4.53x
MQ ranks third and is worth considering specifically for income & stability.
- beta 0.87
- Beta 0.87 vs UPST's 2.96, lower leverage
SOFI is the clearest fit if your priority is long-term compounding.
- 52.7% 10Y total return vs DAVE's -20.5%
DAVE carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 47.5%, EPS growth 222.9%, 3Y rev CAGR 35.7%
- 40.8% margin vs CHYM's -46.2%
- +131.2% vs CHYM's -48.8%
- 49.6% ROA vs CHYM's -49.8%, ROIC 11.1% vs -60.2%
UPST is the #2 pick in this set and the best alternative if bank quality is your priority.
- NIM 5.1% vs SOFI's 4.4%
- 58.9% NII/revenue growth vs MQ's 23.3%
- Lower P/E (14.7x vs 19.1x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 58.9% NII/revenue growth vs MQ's 23.3% | |
| Value | Lower P/E (14.7x vs 19.1x) | |
| Quality / Margins | 40.8% margin vs CHYM's -46.2% | |
| Stability / Safety | Beta 0.87 vs UPST's 2.96, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +131.2% vs CHYM's -48.8% | |
| Efficiency (ROA) | 49.6% ROA vs CHYM's -49.8%, ROIC 11.1% vs -60.2% |
CHYM vs MQ vs SOFI vs DAVE vs UPST — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHYM vs MQ vs SOFI vs DAVE vs UPST — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DAVE leads in 3 of 6 categories
CHYM leads 0 • MQ leads 0 • SOFI leads 0 • UPST leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DAVE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SOFI is the larger business by revenue, generating $4.8B annually — 8.6x DAVE's $552M. DAVE is the more profitable business, keeping 40.8% of every revenue dollar as net income compared to CHYM's -46.2%. On growth, DAVE holds the edge at +36.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.2B | $652M | $4.8B | $552M | $1.1B |
| EBITDAEarnings before interest/tax | -$976M | $5M | $760M | $33M | $68M |
| Net IncomeAfter-tax profit | -$969M | $2M | $481M | $225M | $49M |
| Free Cash FlowCash after capex | $144M | $112M | -$2.6B | $327M | -$146M |
| Gross MarginGross profit ÷ Revenue | +85.9% | +70.0% | +75.1% | +81.5% | +95.2% |
| Operating MarginEBIT ÷ Revenue | -47.6% | -4.0% | +11.0% | +4.9% | +5.1% |
| Net MarginNet income ÷ Revenue | -46.2% | +0.3% | +10.1% | +40.8% | +5.0% |
| FCF MarginFCF ÷ Revenue | +1.5% | +17.2% | -83.5% | +59.2% | -15.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +19.2% | — | +36.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -35.0% | +2.2% | -56.7% | +104.1% | -169.2% |
Valuation Metrics
Evenly matched — MQ and SOFI and UPST each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 18.4x trailing earnings, DAVE trades at a 71% valuation discount to UPST's 64.4x P/E. On an enterprise value basis, SOFI's 22.8x EV/EBITDA is more attractive than DAVE's 69.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.6B | $1.8B | $20.4B | $3.4B | $2.8B |
| Enterprise ValueMkt cap + debt − cash | $7.3B | $817M | $17.3B | $3.3B | $4.0B |
| Trailing P/EPrice ÷ TTM EPS | -7.15x | -139.67x | 41.03x | 18.42x | 64.44x |
| Forward P/EPrice ÷ next-FY EPS est. | 112.89x | 250.90x | 26.45x | 19.07x | 14.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 4.49x |
| EV / EBITDAEnterprise value multiple | — | — | 22.75x | 69.52x | 50.13x |
| Price / SalesMarket cap ÷ Revenue | 3.48x | 2.84x | 4.28x | 6.55x | 2.58x |
| Price / BookPrice ÷ Book value/share | 32.04x | 2.54x | 1.91x | 10.23x | 3.90x |
| Price / FCFMarket cap ÷ FCF | 231.45x | 11.05x | — | 11.57x | — |
Profitability & Efficiency
DAVE leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DAVE delivers a 84.5% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $-68 for CHYM. MQ carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to UPST's 2.32x. On the Piotroski fundamental quality scale (0–9), DAVE scores 5/9 vs SOFI's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -67.9% | +0.3% | +5.9% | +84.5% | +6.6% |
| ROA (TTM)Return on assets | -49.8% | +0.2% | +1.1% | +49.6% | +1.7% |
| ROICReturn on invested capital | -60.2% | — | +3.6% | +11.1% | +1.7% |
| ROCEReturn on capital employed | -78.1% | -3.1% | +1.2% | +12.9% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 3 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.10x | 0.03x | 0.17x | 0.21x | 2.32x |
| Net DebtTotal debt minus cash | -$332M | -$960M | -$3.1B | -$5M | $1.2B |
| Cash & Equiv.Liquid assets | $466M | $982M | $4.9B | $81M | $657M |
| Total DebtShort + long-term debt | $135M | $22M | $1.8B | $75M | $1.9B |
| Interest CoverageEBIT ÷ Interest expense | — | — | 0.45x | 22.86x | 1.66x |
Total Returns (Dividends Reinvested)
DAVE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SOFI five years ago would be worth $9,691 today (with dividends reinvested), compared to $1,373 for MQ. Over the past 12 months, DAVE leads with a +131.2% total return vs CHYM's -48.8%. The 3-year compound annual growth rate (CAGR) favors DAVE at 2.6% vs CHYM's -20.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -28.0% | -9.7% | -41.7% | +13.6% | -36.7% |
| 1-Year ReturnPast 12 months | -48.8% | +2.4% | +23.0% | +131.2% | -37.6% |
| 3-Year ReturnCumulative with dividends | -48.8% | -6.1% | +192.5% | +4740.2% | +116.7% |
| 5-Year ReturnCumulative with dividends | -48.8% | -86.3% | -3.1% | -20.2% | -69.8% |
| 10-Year ReturnCumulative with dividends | -48.8% | -86.3% | +52.7% | -20.5% | -1.6% |
| CAGR (3Y)Annualised 3-year return | -20.0% | -2.1% | +43.0% | +2.6% | +29.4% |
Risk & Volatility
Evenly matched — MQ and DAVE each lead in 1 of 2 comparable metrics.
Risk & Volatility
MQ is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than UPST's 2.96 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DAVE currently trades 86.6% from its 52-week high vs UPST's 33.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.50x | 0.87x | 2.54x | 2.69x | 2.96x |
| 52-Week HighHighest price in past year | $44.94 | $7.04 | $32.73 | $287.69 | $87.30 |
| 52-Week LowLowest price in past year | $16.17 | $3.70 | $12.56 | $105.83 | $23.96 |
| % of 52W HighCurrent price vs 52-week peak | +42.3% | +59.5% | +48.9% | +86.6% | +33.2% |
| RSI (14)Momentum oscillator 0–100 | 50.6 | 45.0 | 41.9 | 51.5 | 42.7 |
| Avg Volume (50D)Average daily shares traded | 4.7M | 3.3M | 65.8M | 607K | 4.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: CHYM as "Buy", MQ as "Hold", SOFI as "Hold", DAVE as "Buy", UPST as "Buy". Consensus price targets imply 55.8% upside for UPST (target: $45) vs 13.4% for MQ (target: $5).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $26.50 | $4.75 | $20.89 | $309.25 | $45.17 |
| # AnalystsCovering analysts | 8 | 22 | 27 | 11 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | 0 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +22.0% | +0.3% | +1.3% | 0.0% |
DAVE leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
CHYM vs MQ vs SOFI vs DAVE vs UPST: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHYM or MQ or SOFI or DAVE or UPST a better buy right now?
For growth investors, Upstart Holdings, Inc.
(UPST) is the stronger pick with 58. 9% revenue growth year-over-year, versus 23. 3% for Marqeta, Inc. (MQ). Dave Inc. (DAVE) offers the better valuation at 18. 4x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Chime Financial, Inc. Class A Common Stock (CHYM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHYM or MQ or SOFI or DAVE or UPST?
On trailing P/E, Dave Inc.
(DAVE) is the cheapest at 18. 4x versus Upstart Holdings, Inc. at 64. 4x. On forward P/E, Upstart Holdings, Inc. is actually cheaper at 14. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CHYM or MQ or SOFI or DAVE or UPST?
Over the past 5 years, SoFi Technologies, Inc.
(SOFI) delivered a total return of -3. 1%, compared to -86. 3% for Marqeta, Inc. (MQ). Over 10 years, the gap is even starker: SOFI returned +52. 7% versus MQ's -86. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHYM or MQ or SOFI or DAVE or UPST?
By beta (market sensitivity over 5 years), Marqeta, Inc.
(MQ) is the lower-risk stock at 0. 87β versus Upstart Holdings, Inc. 's 2. 96β — meaning UPST is approximately 241% more volatile than MQ relative to the S&P 500. On balance sheet safety, Marqeta, Inc. (MQ) carries a lower debt/equity ratio of 3% versus 2% for Upstart Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CHYM or MQ or SOFI or DAVE or UPST?
By revenue growth (latest reported year), Upstart Holdings, Inc.
(UPST) is pulling ahead at 58. 9% versus 23. 3% for Marqeta, Inc. (MQ). On earnings-per-share growth, the picture is similar: Dave Inc. grew EPS 222. 9% year-over-year, compared to -37. 2% for Chime Financial, Inc. Class A Common Stock. Over a 3-year CAGR, DAVE leads at 35. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHYM or MQ or SOFI or DAVE or UPST?
Dave Inc.
(DAVE) is the more profitable company, earning 38. 3% net margin versus -46. 2% for Chime Financial, Inc. Class A Common Stock — meaning it keeps 38. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOFI leads at 11. 0% versus -47. 6% for CHYM. At the gross margin level — before operating expenses — UPST leads at 95. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHYM or MQ or SOFI or DAVE or UPST more undervalued right now?
On forward earnings alone, Upstart Holdings, Inc.
(UPST) trades at 14. 7x forward P/E versus 250. 9x for Marqeta, Inc. — 236. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UPST: 55. 8% to $45. 17.
08Which pays a better dividend — CHYM or MQ or SOFI or DAVE or UPST?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CHYM or MQ or SOFI or DAVE or UPST better for a retirement portfolio?
For long-horizon retirement investors, Marqeta, Inc.
(MQ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 87)). Chime Financial, Inc. Class A Common Stock (CHYM) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MQ: -86. 3%, CHYM: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHYM and MQ and SOFI and DAVE and UPST?
These companies operate in different sectors (CHYM (Financial Services) and MQ (Technology) and SOFI (Financial Services) and DAVE (Technology) and UPST (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.